Print

Invivo Corporation to Participate in 3rd Annual Lazard Capital Markets Medical Technology Conference  
2/15/2011 10:00:45 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that it will participate in the 3rd Annual Lazard Capital Markets Medical Technology Conference in Snowbird, Utah, to take place from Wednesday, February 23rd to Friday, February 25th, 2011.
//-->